Spectrascience 

$0
8
+$0+0% Monday 14:55

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
23,666
Avg. Volume
293,554
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

Financials

-89,340%Profit Margin
Unprofitable
2012
2013
2014
2015
2016
5,000Revenue
-4.47MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SCIE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories, Inc. offers a range of products and services for life science research and clinical diagnostics, competing in the medical diagnostics and research sector similar to Spectrascience.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation operates in the medical, professional, industrial, and commercial products and services, including diagnostics, which competes with Spectrascience's focus.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, directly competing with Spectrascience's offerings.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company is a global medical technology company that manufactures and sells medical devices, instrument systems, and reagents, competing in the diagnostics and research field.
Bruker
BRKR
Mkt Cap5.91B
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions, which competes with Spectrascience's technology in the diagnostics sector.
Agilon Health
AGL
Mkt Cap330.09M
Agilent Technologies, Inc. provides application focused solutions in the life sciences, diagnostics, and applied chemical markets, directly competing with Spectrascience's diagnostic technologies.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products which compete in the women's health sector, overlapping with Spectrascience's market.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health, Inc. focuses on liquid biopsy tests for cancer diagnostics, competing with Spectrascience in the advanced diagnostics and personalized medicine sector.
Illumina
ILMN
Mkt Cap18.99B
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis, competing in the diagnostics and research market similar to Spectrascience.
Qiagen NV
QGEN
Mkt Cap10.16B
QIAGEN N.V. offers sample to insight solutions that transform biological materials into valuable molecular insights, directly competing in the diagnostics and research field with Spectrascience.

About

SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.
Show more...
CEO
Mr. Lowell W. Giffhorn
Employees
5
Country
US
ISIN
US84760E3018

Listings

0 Comments

Share your thoughts

FAQ

What is Spectrascience stock price today?
The current price of SCIE is $0 USD — it has increased by +0% in the past 24 hours. Watch Spectrascience stock price performance more closely on the chart.
What is Spectrascience stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Spectrascience stocks are traded under the ticker SCIE.
What were Spectrascience earnings last quarter?
SCIE earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Spectrascience revenue for the last year?
Spectrascience revenue for the last year amounts to 5,000 USD.
What is Spectrascience net income for the last year?
SCIE net income for the last year is -4.47M USD.
How many employees does Spectrascience have?
As of April 01, 2026, the company has 5 employees.
In which sector is Spectrascience located?
Spectrascience operates in the Health Care sector.
When did Spectrascience complete a stock split?
Spectrascience has not had any recent stock splits.
Where is Spectrascience headquartered?
Spectrascience is headquartered in San Diego, US.